Shanghai, China

Dongqing Li

This inventor holds 1 USPTO granted patent. Top assignee: East China Normal University. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongqing Li. Retrieved from https://idiyas.com/inventor/dongqing-li-nigtv744

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Dongqing Li in Anti-Inflammatory Lipopeptides

Introduction

Dongqing Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biochemistry, particularly in the development of anti-inflammatory compounds. His work focuses on creating innovative solutions to combat inflammation, which is a critical issue in various medical conditions.

Latest Patents

Dongqing Li holds 1 patent for an invention titled "Anti-inflammatory lipopeptide and preparing method and application thereof." This patent discloses an anti-inflammatory lipopeptide that comprises peptide chains and aliphatic chains. The peptide chain is linked to the aliphatic chain through a peptide bond, with an aliphatic acid connected to the N-terminus of the peptide chain. This lipopeptide effectively suppresses inflammatory responses induced by poly(I:C), thereby preventing inflammation after skin injuries and alleviating inflammatory responses associated with skin conditions such as allergic dermatitis. The patent also details a method for preparing this lipopeptide.

Career Highlights

Dongqing Li is affiliated with East China Normal University, where he continues to engage in research and development in the field of biochemistry. His academic background and ongoing research contribute to advancements in medical science, particularly in the area of inflammation management.

Collaborations

Dongqing Li has collaborated with notable colleagues, including Yue H Wang and Hongquan Li. These collaborations enhance the research output and innovation potential within their field.

Conclusion

Dongqing Li's work in developing anti-inflammatory lipopeptides represents a significant advancement in medical research. His innovative approach to addressing inflammation has the potential to improve treatment options for various skin conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…